Phio Pharmaceuticals Corp

NASDAQ:PHIO   1:55:16 PM EDT
2.18
+0.21 (+10.66%)
Earnings Announcements

Phio Pharmaceuticals Reports Second Quarter 2021 Financial Results And Provides Business Update

Published: 08/12/2021 21:12 GMT
Phio Pharmaceuticals Corp (PHIO) - Phio Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides Business Update.
Q2 Loss per Share $0.20.
at June 30, 2021, Company Had Cash of $29.4 Million.
Expects Its Current Cash Will Be Sufficient to Fund Currently Planned Operations to Q2 of 2023.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.25

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.28

More details on our Analysts Page.